Secondary endocrine therapy with oral estrogen for relapsed prostate cancer

Acta Urologica Japonica

Volumn 55, Issue 10, 2009, Pages 595-598

  Onita, Toru ^a   Igawa, Tsukasa ^a   Hisamatsu, Hiroshi ^a   Sakai, Hideki ^a   Kanetake, Hiroshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Oral estrogen; Prostate cancer; Relapse

Indexed keywords

DIETHYLSTILBESTROL; ETHINYLESTRADIOL; PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; HUMAN; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PROSTATE TUMOR; TUMOR RECURRENCE;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; DIETHYLSTILBESTROL; ETHINYL ESTRADIOL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 70749088974     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Huggins C and Hodges G : Studies on prostatic cancer. III. the effects of fever, of desoxycorticostcrone and of estrogen on clinical patients with metastatic carcinoma of the prostate. J Urol 46 : 997-1006, 1941
2. Labrie F, Dupont A, Belanger A, et al.: Combination therapy with flutamide and castration (LH-RH agonist or orchiectomy) in advanced prostate cancer: a marked improvement in response and survival. J Steroid Biochem 23 : 833-841, 1985
3. Scher HI, Mazumdar M and Kelly WK: Clinical trials in relapsed prostate cancer: defining the target. J Natl Cancer Inst 88: 1623-1634, 1996
4. Kitahara S, Yoshida K, Ishizaka K, et al.: Stronger suppression of serum testosterone and FSH levels by a synthetic estrogen than by castration or an LH-RH. Endocr J 44: 527-532, 1997
5. Visakorpi T, Hyytinen E, Koivisto P, et al.: In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 9 : 401-406, 1995
6. Westin P, Brandstrom A, Damber JE, et al.: Castration plus oestrogen treatment induces but castration alone suppresses epithelial cell apoptosis in an androgen-sensitive rat prostatic adenocarcinoma. Br J Cancer 72: 140-145, 1995
7. Robertson CN, Roberson KM, Padilla GM, et al.: Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells. J Natl Cancer Inst 88: 908-917, 1996
8. Akimoto T, Kitamoto Y, Saito J, et al.: External beam radiotherapy for clinically node-negative, localized hormone-refractory prostate cancer: impact of pretreatment PSA value on radiotherapeutic outcomes. Int J Radiat Oncol Biol Phys 59: 372-379, 2004
9. Grady D, Wenger NK, Herrington D, et al.: Postmenopausal hormone therapy increases risk for venous thromboembolic disease. Ann Intern Med 132: 689-696, 2000
10. Petrylac DP, Tangen CM, Hussain MH, et al.: Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced prostate cancer. N Engl J Med 351: 1513-1520, 2004